What is TBPH stock price today?

Visit our real-time dashboard for the current TBPH stock price and live market data.

Is TBPH stock going up or down today?

TBPH stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy TBPH stock now?

The decision to buy TBPH depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is TBPH a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for TBPH based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is TBPH stock overvalued or undervalued?

TBPH currently trades at a P/E ratio of 7.49, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if TBPH is fairly priced.

What is TBPH's P/E ratio?

TBPH has a price-to-earnings (P/E) ratio of 7.49, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is TBPH's market cap?

TBPH (Theravance Biopharma Inc) has a market capitalization of $0.86 billion, making it a small-cap stock.

What is TBPH's price to book ratio?

TBPH trades at a price-to-book (P/B) ratio of 2.96, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does TBPH pay dividends?

TBPH does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is TBPH's dividend yield?

TBPH does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is TBPH stock a good long-term investment?

TBPH's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is TBPH's revenue growth rate?

Revenue growth data for TBPH is available on our dashboard with detailed financial statement analysis.

Profitability metrics for TBPH are available on our dashboard with complete income statement analysis.

What are the risks of investing in TBPH?

Key risks for TBPH include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does TBPH compare to its competitors?

Compare TBPH to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TBPH's performance and positioning.

What is TBPH's stock price target for 2026?

Visit our prediction page for AI-powered price targets for TBPH with bull, base, and bear case scenarios.

What do analysts say about TBPH?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for TBPH. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is TBPH's next earnings report?

TBPH reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

TBPH - Theravance Biopharma Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Theravance Biopharma Inc

Theravance Biopharma Inc (TBPH) common stock

Price Chart

Loading chart...

TBPH Key Statistics

Market Cap

$861.45M

P/E Ratio

7.49

P/B Ratio

2.96

How TBPH Compares to Peers

TBPH has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

TBPH is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
TBPH(This stock)	$861.45M	7.5	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 2:29 PM EDT

Ready to invest in TBPH?

Commission-free trading available. Affiliate links.

TBPH Lician Score

10% confidence

6.0/10

Good

TBPH has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TBPHacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TBPH Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for TBPH

Dashboard

Enter a ticker to analyze